Loading clinical trials...
Loading clinical trials...
The goal of this study is to evaluate the benefit of ACTH (Acthar) in reducing proteinuria associated with transplant glomerulopathy in non-diabetic kidney transplant recipients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Illinois at Chicago
Collaborators
NCT00977977 · Nephrotic Syndrome, Proteinuria, and more
NCT05196035 · Chronic Kidney Disease, Proteinuria
NCT04456816 · Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy
NCT07219121 · Proteinuria, Immunoglobulin A (IgA) Nephropathy, and more
NCT06867471 · Renal Insufficiency, Chronic, Polycystic Kidney Diseases, and more
University of Illinois at Chicago
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions